You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

PENICILLIN G SODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Penicillin G Sodium

A generic version of PENICILLIN G SODIUM was approved as penicillin g sodium by SANDOZ on February 26th, 2001.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PENICILLIN G SODIUM?
  • What are the global sales for PENICILLIN G SODIUM?
  • What is Average Wholesale Price for PENICILLIN G SODIUM?
Drug patent expirations by year for PENICILLIN G SODIUM
Recent Clinical Trials for PENICILLIN G SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cairo UniversityN/A
University of British ColumbiaEarly Phase 1
Haining Health-Coming Biotech Co., Ltd.Phase 2

See all PENICILLIN G SODIUM clinical trials

Pharmacology for PENICILLIN G SODIUM

US Patents and Regulatory Information for PENICILLIN G SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb PENICILLIN G SODIUM penicillin g sodium INJECTABLE;INJECTION 061935-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz PENICILLIN G SODIUM penicillin g sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065068-001 Feb 26, 2001 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Copanos PENICILLIN G SODIUM penicillin g sodium INJECTABLE;INJECTION 061051-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmacia And Upjohn PENICILLIN G SODIUM penicillin g sodium INJECTABLE;INJECTION 061046-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs Inc PENICILLIN G SODIUM penicillin g sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 063014-001 Sep 13, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.